Charles Kouanfack, Faculty of Medicine and Pharmaceutical Sciences University of Dschang

Faculty of Medicine and Pharmaceutical Sciences University of Dschang
Medical Doctor and Phd Public Health

Presenter Of 1 Presentation

Oral abstract session

OAB0402 - Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: Week 96 results of the ANRS 12313 – NAMSAL trial

Presenter Of 1 Presentation

Oral abstract session

Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: Week 96 results of the ANRS 12313 – NAMSAL trial

Presenter Of 1 Presentation

Oral abstract session

Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: Week 96 results of the ANRS 12313 – NAMSAL trial